Searched for
BIOTECH GROWTH IN INDIA
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Sunil Singhania-backed Abakkus Small Cap Fund adds 3 new stocks, increases stake in HDFC Bank, SBI and 49 othersSunil Singhania's Abakkus Small Cap Fund added three new stocks in May, including Tanla Platforms and Intellect Design Arena. The fund also...
- India's agriculture and water tech startups gain momentum, sustainability in focus: NasscomIndia's agri and water tech deeptech ecosystem is gaining momentum around commercialization as per a statement by Nasscom. These sectors st...
- Team Europe to visit Assam on June 8-9 to launch India's first Blue Valley clusterGuwahati, Assam, is preparing to welcome a distinguished European Union delegation on June 8-9, as part of a mission to strengthen ties bet...
- H-1B chill sets in; Flipkart doubles down on ShopsyUS demand for H-1B visas has slumped to a seven-year low amid steeper costs and Trump-era policy shifts. This and more in today’s ETtech To...
- VCs eye deeptech fund launches to leverage RDI capitalSector-agnostic VC firms Kalaari Capital and Blue Ashva Capital are among those exploring new deeptech-focussed vehicles amid rising invest...
- Flipkart puts IPO on ice; Rapido's $240 million raiseFlipkart has hit pause on its IPO in a jittery market. This and more in today's ETtech Top 5.
- Karnataka to strengthen collaboration with Chile across digital services, startups, talent exchangeKarnataka is set to enhance its digital services, startup ecosystem, and talent exchange with Chile. A high-level meeting explored partners...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- Deeptech bets heat up; Paytm, PB Fintech, Meesho earningsHappy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...
- Early-stage tech draws VC interest across aviation, biotech, precision manufacturingInvestors are prioritising smaller, early-stage deals in deeptech sectors like AI, healthcare, and precision manufacturing, shying away fro...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- Two separate venues for pharma industry expos in Delhi-NCRCPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Forget the noise: These 54 smallcap stocks attracted FII buying in March quarterForeign institutional investors are strategically buying into beaten-down smallcap stocks in India, increasing stakes in 54 companies despi...
- ETMarkets Smart Talk | India expensive, Taiwan & Korea offer value: Nikhil Advani on global investingIndian equities face rich valuations, prompting investors to look globally. Nikhil Advani of LGT Wealth India highlights opportunities in e...
- From FAANG to BATMMAAN: the new acronym driving global tech investing, says Niteen DongareGlobal investors are shifting focus from FAANG and Magnificent 7 to broader innovation, embracing the BATMMAAN acronym for AI, semiconducto...
- Anthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialShares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Ana...
- Inside China’s ‘Magic’ factories: The tech playbook India can’t ignoreChina's state-of-the-art factories reflect its commitment to innovation, backed by robust research and development initiatives. This enviro...
Load More
